Literature DB >> 21297380

New therapeutic algorithm of Type 2 diabetes: lights and shadows.

A Consoli1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21297380     DOI: 10.1007/BF03346697

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  22 in total

1.  Grading quality of evidence and strength of recommendations.

Authors:  David Atkins; Dana Best; Peter A Briss; Martin Eccles; Yngve Falck-Ytter; Signe Flottorp; Gordon H Guyatt; Robin T Harbour; Margaret C Haugh; David Henry; Suzanne Hill; Roman Jaeschke; Gillian Leng; Alessandro Liberati; Nicola Magrini; James Mason; Philippa Middleton; Jacek Mrukowicz; Dianne O'Connell; Andrew D Oxman; Bob Phillips; Holger J Schünemann; Tessa Tan-Torres Edejer; Helena Varonen; Gunn E Vist; John W Williams; Stephanie Zaza
Journal:  BMJ       Date:  2004-06-19

2.  What are the practical implications for treating diabetes in light of recent evidence? Updated recommendations from the Global Partnership for Effective Diabetes Management.

Authors:  Clifford J Bailey; Lawrence Blonde; Stefano Del Prato; Lawrence A Leiter; Richard Nesto
Journal:  Diab Vasc Dis Res       Date:  2009-10       Impact factor: 3.291

3.  Understanding the inter-relationship between improved glycaemic control, hypoglycaemia and weight change within a long-term economic model.

Authors:  P McEwan; M Evans; H Kan; K Bergenheim
Journal:  Diabetes Obes Metab       Date:  2010-05       Impact factor: 6.577

4.  Improving glucose management: ten steps to get more patients with type 2 diabetes to glycaemic goal.

Authors:  S Del Prato; A-M Felton; N Munro; R Nesto; P Zimmet; B Zinman
Journal:  Int J Clin Pract       Date:  2005-11       Impact factor: 2.503

5.  Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control.

Authors:  Helena W Rodbard; Paul S Jellinger; Jaime A Davidson; Daniel Einhorn; Alan J Garber; George Grunberger; Yehuda Handelsman; Edward S Horton; Harold Lebovitz; Philip Levy; Etie S Moghissi; Stanley S Schwartz
Journal:  Endocr Pract       Date:  2009 Sep-Oct       Impact factor: 3.443

6.  Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy.

Authors:  E Ferrannini; V Fonseca; B Zinman; D Matthews; B Ahrén; S Byiers; Q Shao; S Dejager
Journal:  Diabetes Obes Metab       Date:  2009-02       Impact factor: 6.577

Review 7.  Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis.

Authors:  Renee E Amori; Joseph Lau; Anastassios G Pittas
Journal:  JAMA       Date:  2007-07-11       Impact factor: 56.272

Review 8.  Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus.

Authors:  Shari Bolen; Leonard Feldman; Jason Vassy; Lisa Wilson; Hsin-Chieh Yeh; Spyridon Marinopoulos; Crystal Wiley; Elizabeth Selvin; Renee Wilson; Eric B Bass; Frederick L Brancati
Journal:  Ann Intern Med       Date:  2007-07-16       Impact factor: 25.391

9.  Comparison of different drugs as add-on treatments to metformin in type 2 diabetes: a meta-analysis.

Authors:  Matteo Monami; Caterina Lamanna; Niccolò Marchionni; Edoardo Mannucci
Journal:  Diabetes Res Clin Pract       Date:  2007-10-10       Impact factor: 5.602

10.  Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus.

Authors:  Ralph A Defronzo
Journal:  Diabetes       Date:  2009-04       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.